vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) has once again raised its full-year outlook on
Justin Sullivan The Department of Justice has objected to Johnson & Johnson’s third attempt to
JHVEPhoto Abiomed, a division of Johnson & Johnson (NYSE:JNJ) MedTech, said that an investigational device
JHVEPhoto/iStock Editorial via Getty Images A phase 3 study found that a subcutaneous version of
Michael Vi/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) reported positive data from a
Matteo Colombo Following a three-day selloff, Contineum Therapeutics (NASDAQ:CTNM) traded higher on Tuesday after Baird
Johnson & Johnson (NYSE:JNJ) shares traded in the red on Monday, snapping six consecutive days
Scott Olson/Getty Images News Activist investor Starboard Value has amassed a sizeable stake in Kenvue
Summary: J&J’s Q3 2024 earnings beat expectations with $22.5B in revenue, driven by strong performances
Summary: Johnson & Johnson reported solid Q3 revenues of $22.5bn, up 5.2% YoY, despite a